June 2011 Volume 7, Issue 6

Volume 7, Issue 6 | June 2011

June 2011

In this Issue

Research & Development

Drug Discovery News Placeholder Image

One for the history books

In its largest acquisition to date, Johnson & Johnson acquires medical device maker Synthes for $21.3 billion, creating the world’s largest orthopedics business
Drug Discovery News Placeholder Image

Right fit, right time

Alkermes and Élan Drug Technologies announce $960 million merger, creating leader in CNS therapeutics
Drug Discovery News Placeholder Image

What's Next(erone) for Baxter?

Pharma giant acquires Ligand partner Prism to bring Nexterone, an anti-arrhythmic agent, to market
Drug Discovery News Placeholder Image

BBB and beyond

Lilly, Medtronic collaborate on crossing blood brain barrier to combat Parkinson’s disease
Drug Discovery News Placeholder Image

Striking a ‘cord’ with spinal injuries

InVivo, UMiami collaboration to combine SCI technologies for treatment

Instruments & Informatics

Drug Discovery News Placeholder Image

Two’s a cloud

PerkinElmer acquires Geospiza, a leading developer of cloud computing software
Drug Discovery News Placeholder Image

Imaging is everything

GE Healthcare to acquire cellular imaging company Applied Precision as part of its life-science expansion plans
Drug Discovery News Placeholder Image

Avantor acquires POCH from Kulczyk Holding

Acquisition of Poland’s leading performance materials supplier will expand Avantor’s laboratory offering and manufacturing footprint in Eastern Europe
Drug Discovery News Placeholder Image

License to drive

Sigma Life Science commercializes technology from King’s College London that eases miRNA target identification bottlenecks
Drug Discovery News Placeholder Image

The future of work

Cognizant, Eagle Genomics work with Pistoia Alliance to develop cloud-based platform to streamline sequencing services

Omics & Systems Biology

Drug Discovery News Placeholder Image

Playing by the Rules

Myriad acquires Austin-based Rules- Based Medicine for $80 million, boosting capabilities in biomarker discovery
Drug Discovery News Placeholder Image

Taking the path of least resistance

Gene-editing collaboration to fight EGFR- targeted therapy resistance
Drug Discovery News Placeholder Image

Surf’s up for microRNAs

Regulus Therapeutics, UCSD collaborate on angiogenic disease research utilizing microRNA technology
Drug Discovery News Placeholder Image

Wet or dry, hope for the eye

Tufts researchers find protein CD59 is key to slowing age-related macular degeneration
Drug Discovery News Placeholder Image

Creating cancer for the greater good

Researchers make normal stem cells into cancer stem cells and achieve important insights into triple-negative breast cancer

Editor's Focus

Drug Discovery News Placeholder Image

Will open access open a Pandora’s box for scientific journals?

Should the content in scientific journals be made available to the public? There are unintended consequences to opening up copyrighted material, as evidenced by the many challenges facing the journalism business since Al Gore 'invented' the Internet.

Commentary

Drug Discovery News Placeholder Image

New tools take time

It’s been a rough first half in 2011, but beneath the noise, much progress is being made, and the last five years have been a lot more productive than we take time to realize.
Drug Discovery News Placeholder Image

Guest Commentary: Generating more knowledge from data and more value from studies

The nature of drug discovery and development remains an information-rich endeavor, and in order to increase success rates, we must make better use of our data—and our information science experts.

Global News

Drug Discovery News Placeholder Image

Back to school

Swiss developer Debiopharm and Yale in licensing deal on inhibitor for autoimmune and inflammatory diseases
Drug Discovery News Placeholder Image

Taking cancer to TASQ

Active Biotech and Ipsen partner on Tasquinimod TASQ compound in uro-oncology
Drug Discovery News Placeholder Image

Once-in-a-decade breakthrough

Alnylam and Precision NanoSystems form RNAi delivery collaboration
Drug Discovery News Placeholder Image

A helping hand in India

Swedish pharma Karo Bio and Indian pharma Alkem Laboratories Ltd. to develop eprotirome for dyslipidemia

Diagnostics

Drug Discovery News Placeholder Image

Alzheimer’s disease: First steps to stem the epidemic

AD guidelines updated for the first time in decades; NIH-supported revision also proposes staging of disease, potential use of biomarkers
Drug Discovery News Placeholder Image

A wide spectrum narrows

SynapDx licenses autism diagnostic discoveries from Children’s Hospital Boston
Drug Discovery News Placeholder Image

Multiplex makes for a magnetic attraction

Applied BioCode announces strategic technology partnership, license agreement with EraGen Biosciences
Drug Discovery News Placeholder Image

In NARMS way

Magellan Biosciences and miacom diagnostics partner to speed up identification of pathogens, streamline lab workflow and enable better treatment decisions

Contract Services

Drug Discovery News Placeholder Image

Controlling their own destiny

Nautic Partners acquires Omnicare’s CRO arm
Drug Discovery News Placeholder Image

Entrée into the Orient

Mitsui acquires MBS and expands geographic base
Drug Discovery News Placeholder Image

Serving up ‘plate-to-patient’ fare

Quotient Bioresearch and KWS BioTest partner on end-to-end anti-infectives screening
Drug Discovery News Placeholder Image

A public-private partnership

Paragon, UMB and Life Technologies to develop stem-cell therapies

Feature

Drug Discovery News Placeholder Image

Look at what’s new in D.C.

Program for 2011 BIO International Convention seeks to provide attendees with a well-rounded knowledge base they can use to advance business objectives
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue